Profile
DHR-PB TMO DHR IDXX A IQV
Company Name Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc. IQVIA Holdings Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $916.76B $155.57B $143.61B $42.73B $33.26B $27.24B
Employees 79.00K 125.00K 61.00K 11.00K 17.90K 89.00K
CEO Rainer M. Blair Marc N. Casper Mr. Rainer M. Blair Jonathan J. Mazelsky Mr. Padraig McDonnell Ari Bousbib
Ratings
DHR-PB TMO DHR IDXX A IQV
Quant Rating Score 5 3 3 3 3 3
Quant Rating Strong Buy Neutral Neutral Neutral Neutral Neutral
Trading
DHR-PB TMO DHR IDXX A IQV
Last Close $1261.26 $405.46 $197.54 $536.34 $118.01 $157.59
High 52 $1261.26 $624.21 $280.76 $536.34 $152.6 $251.55
Low 52 $1261.26 $390.2 $174.64 $361.04 $99.29 $137
Price vs. 52 Week High 0 % -35.04 % -29.64 % 0 % -22.67 % -37.35 %
Price vs. 52 Week Low 0 % 3.91 % 13.11 % 48.55 % 18.85 % 15.03 %
Total Return
DHR-PB TMO DHR IDXX A IQV
1 Month Return 0 % 0.66 % 4.02 % 4.48 % 5.44 % 12.3 %
3 Month Return 0 % -16.04 % -1.39 % 28.14 % 3.47 % -7.97 %
6 Month Return 0 % -22.06 % -13.94 % 29.73 % -12.16 % -19.81 %
9 Month Return 0 % -33.85 % -28.05 % 8.26 % -19.48 % -31.89 %
YTD Return 0 % -22.06 % -13.94 % 29.73 % -12.16 % -19.81 %
1 Year Return 0 % -25.15 % -19.21 % 12.58 % -7.37 % -24.41 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PB TMO DHR IDXX A IQV
Dividend Yield Percentage (TTM) 0.59 % 0.4 % 0.56 % - 0.83 % -
Dividend Paid and Capex Coverage Ration (TTM) 2.93 % 4.05 % 2.93 % 7.41 % 3.43 % 4.61 %
Dividend Per Share (TTM) 1.18 % 1.64 % 1.13 % - 0.97 % -
Payout Ratio (TTM) 20.85 % 9.16 % 20.85 % - 23.76 % -
Profitability
DHR-PB TMO DHR IDXX A IQV
Gross Profit Margin TTM 59.74 % 41.57 % 59.74 % 61.32 % 53.79 % 34.72 %
Return on Assets TTM 4.76 % 6.58 % 4.76 % 27.85 % 9.59 % 4.88 %
Return on Equity TTM 7.47 % 13.34 % 7.47 % 57.35 % 19.46 % 20.74 %
Return on Capital Employed TTM 6.66 % 8.53 % 6.66 % 55.24 % 13.97 % 10.65 %
Net Income Per EBT TTM 83.59 % 92.18 % 83.59 % 79.59 % 85.05 % 80.75 %
EBT Per Ebit TTM 93.35 % 96.45 % 93.35 % 97.98 % 96.75 % 76.98 %
EBIT Per Revenue TTM 20.26 % 17.08 % 20.26 % 29.19 % 21.38 % 13.85 %
Cash Flow To Debt Ratio TTM 37.92 % 23.81 % 37.92 % 91.41 % 45.35 % 19.04 %
Receivables Turnover TTM 6.79 5.07 6.79 6.51 4.85 4.68
Payables Turnover TTM 5.57 - 5.57 12.66 5.94 2.84
Inventory Turnover TTM 3.79 4.8 3.79 3.84 3.1 -
Fixed Asset Turnover TTM 466.14 % 459.74 % 466.14 % 471.66 % 346.65 % 2017.84 %
Asset Turnover TTM 30.11 % 43.31 % 30.11 % 122.35 % 54.52 % 56.72 %
Operating Cash Flow Per Share TTM 8.72 21.53 8.72 11.91 5.56 15.72
Free Cash Flow Per Share TTM 6.84 17.79 6.84 10.3 4.91 12.31
Cash Per Share TTM 278.24 % 1573.28 % 278.24 % 201.64 % 521.4 % 1067.73 %
Operating Cash Flow Sales Ratio TTM 26.23 % 18.97 % 26.23 % 24.63 % 23.91 % 17.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.46 % 82.61 % 78.46 % 86.51 % 88.33 % 78.31 %
Cash Flow Coverage Ratios TTM 37.92 % 23.81 % 37.92 % 91.41 % 45.35 % 19.04 %
Price To Free Cash Flows Ratio TTM 29.02 23.14 29.3 51.01 23.76 12.59
Price To Operating Cash Flows Ratio TTM 22.79 19.14 23.01 44.62 21.05 10.02
Price Cash Flow Ratio TTM 22.79 19.14 23.01 44.62 21.05 10.02
Income Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Revenue $23.88B $42.88B $23.88B $3.9B $6.51B $15.41B
Gross Profit $14.21B $17.7B $14.21B $2.38B $3.54B $5.38B
Gross Profit Ratio 59.5% 41.28% 59.5% 61.04% 54.3% 34.89%
EBITDA $7.28B $11.8B $7.28B $1.28B $1.87B $3.49B
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
EPS Diluted 5.29 16.53 5.29 10.67 4.43 7.49
Balance Sheet (MRQ)
DHR-PB TMO DHR IDXX A IQV
Long Term Debt $15.5B $29.06B $15.5B $0.55B $3.35B $13.23B
Total Liabilities $27.99B $47.65B $27.99B $1.7B $5.95B $20.83B
Total Equity $49.55B $49.67B $49.55B $1.6B $5.9B $6.07B
Total Investments $0B $1.56B $0B $0.06B $0.18B $0.52B
Total Debt $16.01B $31.28B $16.01B $0.99B $3.39B $14.16B
Total Assets $77.54B $97.32B $77.54B $3.29B $11.85B $26.9B
Cash Flow Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
Inventory $0.15B $0B $0.15B $-0.03B $0.03B $0B
Dividends Paid $-0.77B $-0.58B $-0.77B $0B $-0.27B $0B
Operating Cash Flow $6.69B $8.67B $6.69B $0.93B $1.75B $2.72B
Capital Expenditure $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B $-0.6B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 120.45
ACRS Aclaris Therapeutics, Inc. 1.4
ADVB Advanced Biomed Inc. Common Stock 0.724
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 4.56
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.2879
BIAF bioAffinity Technologies, Inc. 0.2632
BIAFW bioAffinity Technologies, Inc. 0.1392
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.29
BNR Burning Rock Biotech Limited 3.23
CDNA CareDx, Inc 18.85
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.76
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 154.405
CSTL Castle Biosciences, Inc. 20.36
DGX Quest Diagnostics Incorporated 179.3
Unlock